Skip to main content
. 2013 Oct 18;8(10):e76882. doi: 10.1371/journal.pone.0076882

Table 2. Duration of each line of treatment.

TRD episodesa(N = 3,134) Non-TRD episodes (with at least one ADAP prescription)(N = 44,520) p (Ho: MT = MN; H1: MT<>MN)
Line of Treatment N Median duration(In days) Mean duration(In days) N Median duration(In days) Mean duration(In days) Comparing Mean Duration(In days)
LOT 1 3,134 93 (55–223) 183 44,520 114 (38–322) 257 <0.001
LOT 2 3,134 69 (48–147) 139 9,952 83 (42–204) 192 <0.001
LOT 3 3,134 72 (45–183) 157 4,341 141 (62–348) 267 <0.001
LOT 4 2,406 84 (47–196) 171 1,512 98 (53–252) 210 <0.001
LOT 5 1,651 85 (49–190) 167 763 114 (56–275) 222 <0.001
LOT 6 1,142 85 (49–165) 154 333 95 (59–228) 188 0.01
LOT 7 794 83 (46–166) 161 185 99 (56–220) 194 0.04
LOT 8 545 87 (45–191) 157 99 106 (49–251) 201 0.05
LOT 9 379 79 (45–170) 144 49 91 (59–148) 154 0.71
LOT 10 264 79 (46–151) 151 26 79 (51–237) 184 0.48

Figures in brackets represent lower and upper quartile limits.

Abbreviations: ADAP: Antidepressant and antipsychotic/antimanic drugs; p = p-value; H0 = Null Hypothesis, H1 = Alternative Hypothesis; MT = the average duration of a LOT in TRD episodes, MN = the average duration of a LOT in non-TRD episodes; LOT = Line of therapy.

a

An episode will have at least 3 lines of treatment to qualify as TRD, based on the definition stated in the Methods section.